RCKT
Rocket Pharmaceuticals, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang -7.7% ·
aliran saham -30.0% ·
posisi baru bersih -8.3%
— formula
Distribusi luas — penurunan saham dan lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | -1 | 55.09M | $188.40M | +4 | −5 |
| Q1 2026 | 83 | +2 | 57.14M | $204.44M | +8 | −6 |
| Q4 2025 | 81 | +2 | 51.01M | $179.05M | +2 | — |
| Q3 2025 | 15 | 0 | 38.20M | $124.54M | — | — |
| Q2 2025 | 12 | -1 | 25.35M | $62.12M | +2 | −3 |
| Q1 2025 | 10 | -1 | 24.61M | $164.16M | +1 | −2 |
| Q4 2024 | 11 | 0 | 29.17M | $366.63M | +1 | −1 |
| Q3 2024 | 10 | 0 | 19.68M | $363.43M | +2 | −2 |
| Q2 2024 | 10 | — | 17.23M | $370.95M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (pasif) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (pasif) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (pasif) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (pasif) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (pasif) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (pasif) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Millennium Management ✦ | 2.35M | +214.4% | $5.75M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Geode Capital Management ✦ (pasif) | 2.03M | +1.9% | $4.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Geode Capital Management ✦ (pasif) | 2.03M | +1.9% | $4.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | State Street Global Advisors ✦ (pasif) | 1.94M | -47.5% | $4.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | Two Sigma Investments ✦ | 1.73M | Baru | $4.23M | 0.0% | New | 1 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 1.10M | -63.9% | $2.70M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | T. Rowe Price ✦ | 1.10M | -63.9% | $2.70M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 992.83K | Baru | $2.43M | 0.0% | New | 1 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 992.83K | Baru | $2.43M | 0.0% | New | 1 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 777.67K | +375.3% | $1.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 777.67K | +375.3% | $1.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 777.67K | +375.3% | $1.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 777.67K | +375.3% | $1.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 35 | Renaissance Technologies ✦ | 461.37K | +36.3% | $1.13M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 266.05K | — | $651,819 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 266.05K | — | $651,819 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Citadel Advisors ✦ | 156.05K | -89.7% | $382,322 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Citadel Advisors ✦ | 156.05K | -89.7% | $382,322 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Two Sigma Investments | $4.23M | 0.0% |
| D. E. Shaw & Co. | $2.43M | 0.0% |
| D. E. Shaw & Co. | $2.43M | 0.0% |
Telah keluar
| Wellington Management | $84.22M | adalah 0.0% |
| Marshall Wace | $2.93M | adalah 0.0% |
| Norges Bank | $295,441 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 195 pemegang, 96.37M saham, $341.40M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 2.29K lbr · $7,753
Officer · 631 lbr · $2,133
Officer · 4.70K lbr · $16,449
Officer · 36.66K lbr · $128,266
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi